Literature DB >> 19064792

Clinical trials of stroke therapy: which cells, which patients?

Lawrence R Wechsler1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19064792     DOI: 10.1161/STROKEAHA.108.533208

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

Review 1.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

2.  The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells.

Authors:  R El Khoury; V Misra; S Sharma; C S Cox; P Walker; J C Grotta; A Gee; S Suzuki; S I Savitz
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

Review 3.  Optimizing the success of cell transplantation therapy for stroke.

Authors:  Tonya M Bliss; Robert H Andres; Gary K Steinberg
Journal:  Neurobiol Dis       Date:  2009-10-12       Impact factor: 7.046

Review 4.  Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations.

Authors:  Brad B Swelstad; Candace L Kerr
Journal:  Stem Cells Cloning       Date:  2009-12-22

5.  Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.

Authors:  Suk Jae Kim; Gyeong Joon Moon; Won Hyuk Chang; Yun-Hee Kim; Oh Young Bang
Journal:  Trials       Date:  2013-10-01       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.